F759 in New Hampshire. Pick another state for the same tag.
Against expectation — 2025
New Hampshire cites F759 more often than its own record predicts
Versus expected share1.33×
1.33 times the share F759 takes of citations nationally.
Share of New Hampshire citations1.44%
Of every deficiency written in New Hampshire in 2025, this is the portion that was F759.
New Hampshire1.44%
National1.08%
Share of all citations that were F759.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What New Hampshire surveyors wrote
F759 findings written in New Hampshire, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedApril 30, 2026
Based on observation, interview, and record review, the facility failed to ensure that medication error rate remained below 5 percent for 4 of 34 opportunities of medication administration observed. (Resident identifiers are #41 and #46.)Findings include: Resident #46 Observation on 4/29/26 at approximately 8:45 a.m. with Staff A (Licensed Practical Nurse) during Resident #46's medication administration revealed that Staff A prepared Resident #46' scheduled morning medication and placed the oral medications in a medication cup that included one Over-The-Counter (OTC) Calcium with Vitamin D 600 mg-200 unit tablet, one Metoprolol Tartrate 12.5 milligram (mg) dose tablet, and one Digoxin 125 microgram (mcg) tablet. …
B · No harm, potential for minimal, patternSeptember 11, 2018
Based on observation, record review and interview, it was determined that the facility failed to ensure that the medication error rate was not greater than 5% during 32 medication pass observations. (Resident identifier is #217.)
Findings include:
Resident #217
Observation on 9/6/18 at approximately 11:06 a.m. during medication pass revealed that Resident #217 received the following scheduled 9:00 A.M. medications; Aspirin 81 mg (milligrams) (1 tablet) by mouth one time a day, [MEDICATION NAME] 40 mg (1 tablet) by mouth one time a day, ROPINIRole HCI 1 mg (1 tablet) by mouth one time a day, [MEDICATION NAME] HCI 100 mg (1 tablet) by mouth one time a day, [MEDICATION NAME] HCI 25 mg (1 tablet) by mouth one time a day, [MEDICATION NAME] 50 mg by mouth (two times a day), and Micro-K Extended… …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction